High dose antipsychotic use in schizophrenia: Findings of the REAP (Research on East Asia Psychotropic Prescriptions) study
10.1055/s-2004-827174
Saved in:
Main Authors: | Sim, K., Su, A., Leong, J.Y., Yip, K., Chong, M.-Y., Yang, S., Tsang, H.-Y., Fujii, S., Shinfuku, N., Ungvari, G.S., Si, T., Chung, E.K., Kua, E.H., Tan, C.H. |
---|---|
Other Authors: | PSYCHOLOGICAL MEDICINE |
Format: | Article |
Published: |
2012
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/34122 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
High dose antipsychotic use in schizophrenia: Findings of the REAP (Research on East Asia Psychotropic Prescriptions) study
by: Sim, K., et al.
Published: (2016) -
High-dose antipsychotic use in schizophrenia: A comparison between the 2001 and 2004 Research on East Asia Psychotropic Prescription (REAP) studies
by: Sim, K., et al.
Published: (2011) -
Sex differences in use of psychotropic drugs and drug-induced side effects in schizophrenia patients: Findings of the Research on Asia Psychotropic Prescription (REAP) studies
by: Xiang, Y.-T., et al.
Published: (2016) -
Clozapine use in schizophrenia: Findings of the Research on Asia Psychotropic Prescription (REAP) studies from 2001 to 2009
by: Xiang, Y.-T., et al.
Published: (2016) -
Tardive dyskinesia in the treatment of schizophrenia: The findings of the Research on Asian Psychotropic Prescription Pattern (REAP) survey (2001-2009)
by: Xiang, Y.-T., et al.
Published: (2016)